Synaptic pathology: A shared mechanism in neurological disease

[Display omitted] •Synaptic changes occur early in most neurodegenerative diseases.•Synaptic changes likely contribute to cognitive decline in ageing.•Targeting synaptic pathology is a promising therapeutic strategy. Synaptic proteomes have evolved a rich and complex diversity to allow the exquisite...

Full description

Saved in:
Bibliographic Details
Published inAgeing research reviews Vol. 28; pp. 72 - 84
Main Authors Henstridge, Christopher M., Pickett, Eleanor, Spires-Jones, Tara L.
Format Journal Article
LanguageEnglish
Published England Elsevier B.V 01.07.2016
Subjects
Online AccessGet full text
ISSN1568-1637
1872-9649
1872-9649
DOI10.1016/j.arr.2016.04.005

Cover

More Information
Summary:[Display omitted] •Synaptic changes occur early in most neurodegenerative diseases.•Synaptic changes likely contribute to cognitive decline in ageing.•Targeting synaptic pathology is a promising therapeutic strategy. Synaptic proteomes have evolved a rich and complex diversity to allow the exquisite control of neuronal communication and information transfer. It is therefore not surprising that many neurological disorders are associated with alterations in synaptic function. As technology has advanced, our ability to study the anatomical and physiological function of synapses in greater detail has revealed a critical role for both central and peripheral synapses in neurodegenerative disease. Synapse loss has a devastating effect on cellular communication, leading to wide ranging effects such as network disruption within central neural systems and muscle wastage in the periphery. These devastating effects link synaptic pathology to a diverse range of neurological disorders, spanning Alzheimer’s disease to multiple sclerosis. This review will highlight some of the current literature on synaptic integrity in animal models of disease and human post-mortem studies. Synaptic changes in normal brain ageing will also be discussed and finally the current and prospective treatments for neurodegenerative disorders will be summarised.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1568-1637
1872-9649
1872-9649
DOI:10.1016/j.arr.2016.04.005